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Abstract The authors report two cases of complicated
dengue viral infection with acute myocarditis involving
young male adults, of which one was fatal. The first case
presented with typical signs of myocardial disease: chest
pain and diaphoresis with myocardial depression in the
electrocardiograph. The second case deteriorated rapidly
and demised within the first day of admission. Histology of
the heart muscles showed multiple small foci of myocyte
necrosis surrounded by lymphocytes, in keeping with viral
myocarditis. Both cases fulfilled the World Health Orga-
nization (WHO) diagnosis of probable dengue: the first
case had positive dengue serology, both IgM and IgG at
day six of illness, and the second case was polymerase
chain reaction (PCR) positive for dengue and identified as
serotype 2. Despite the severe outcome, both cases did not
completely fulfil the criteria for dengue haemorrhagic fever
(DHF). Although severe cardiac impairment is not com-
monly reported in dengue infection, it can be life
threatening.
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Introduction
Dengue is the most prevalent arthropod-borne viral disease,
with an alarming global burden in tropical and subtropical
regions and the potential for further geographic spread.
Dengue is hyperendemic in Singapore, with all four
serotypes in co-circulation all year round. The dengue
incidence rate was 98.1/100,000 population in 2010, with a
case–fatality ratio of 0.08 % [1]. Although the incidence
rate was not the highest in the Asia–Pacific region, the
disease had high economic impact [2]. It was estimated that
the average economic impact of dengue illness in Singa-
pore over one 10-year period from 2000 to 2009 was
between US$ 0.85 billion and US$ 1.15 billion [2].
The clinical features of dengue range from asymptom-
atic and subclinical infection to typical dengue fever, with
a small proportion suffering from severe illness presenting
with plasma leakage, bleeding or organ involvement.
Dengue fatality is unusual, particularly among adults.
Dengue fever classically comprises a febrile phase that
spans 3–7 days, followed by a critical phase around the
time of defervescence. This critical phase is when systemic
vascular leakage may occur, which, in severe cases, may
lead to shock and where haemorrhagic manifestations are
most common. Subsequently, there is a recovery phase
lasting several days, with normalisation of blood counts
and haemodynamic parameters. Less common presenta-
tions such as encephalitis, liver failure, retinitis or myo-
carditis have been also reported. Although the cardiac
complications of dengue are rare, asymptomatic myocar-
dial involvement has been documented [3]. Acute myo-
carditis is the most common cardiac pathology described in
cases that succumbed to dengue shock syndrome [4–6].
The authors report two cases of dengue complicated
with acute myocarditis. One patient died after a sudden
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onset of restlessness and acute myocarditis was diagnosed
post mortem according to autopsy findings. As dengue
management is challenging, often with an unpredictable
clinical course and outcome, we aim to emphasise that
atypical manifestations can occur and can be life
threatening.
Case 1
A 20-year-old Chinese Singaporean male presented to the
Emergency Department on January 12th, 2011, complain-
ing of fever for the last 5 days, associated with occasional
vomiting and nausea. He denied other complaints, includ-
ing diarrhoea, cough, sore throat, rhinorrhoea, dyspnoea,
headache, myalgia, arthralgia, abdominal pain and dysuria.
However, he had noticed redness over bilateral thighs since
that morning and denied any bleeding. He had a history of
childhood asthma but no other significant past medical
history, and did not have a history of drug, tobacco or
alcohol abuse.
His tympanic temperature was 36.3 C, pulse rate
116/min, respiratory rate 18/min, blood pressure
118/71 mmHg and a generalised petechial rash was found
on physical examination. He was noted to be moderately
obese (body mass index: 31.28 kg/m2). An electrocardio-
gram (ECG) showed slight sinus tachycardia (102 bpm)
(Fig. 1). Laboratory data revealed thrombocytopaenia
(14 9 109/L; normal range 170–420 9 109/L), increased
values of haematocrit (54.5 %; normal range 41–51 %) and
haemoglobin (18.1 g/dL; normal range 13–17 g/dL), total
leukocyte count (6.5 9 109/L; normal range
3.6–9.3 9 109/L), prolonged activated partial thrombo-
plastin time (45.9 s; normal range 25–36 s) and an
increased serum creatinine level of 124 lmol/L (normal
range 60–105 lmol/L).
He was given intravenous hydration while under the
Infectious Diseases service, with the presumptive diagnosis
of dengue. Dengue IgM and IgG were positive on serum
collected at the sixth day of illness. He was haemody-
namically stable from admission, but on the third day of
admission (seventh day of illness), he complained of cen-
tral chest pain, nausea, vomiting and diaphoresis of sudden
onset. No signs of bleeding or hypotension were noted and
his pulse rate was 98/min. His platelet count had risen to
36 9 109/L and haematocrit decreased to 46.8 %. Troponin
I serum level was 3.06 lg/L (normal range 0.0–0.5 lg/L)
and his hepatic and renal functions were normal. Chest
radiography showed no signs of fluid overload or pul-
monary consolidations, and his cardiothoracic ratio was
normal. ECG disclosed widespread ST-segment elevations
and T-wave inversions (Fig. 2). Transthoracic echocardi-
ography revealed a left ventricular systolic dysfunction
with mild hypokinesia and an ejection fraction of 45 %.
Treatment under close monitoring in the High Dependency
Unit included a single dose of 300 mg acetylsalicylic acid,
bisoprolol 2.5 mg OD and enalapril 1.25 mg BD.
The patient’s clinical status improved subsequently,
with ST-segment normalisation (Fig. 3). He was dis-
charged after five inpatient days with full resolution of
Fig. 1 Slight sinus tachycardia
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symptoms, platelet count of 122 9 109/L and haematocrit
of 48.7 %. He was well at clinic review a month later.
Case 2
A 41-year-old Chinese male presented to the Emergency
Department on March 21st, 2011, with a two-day history of
fever, chills, generalised myalgia and arthralgia. He denied
other complaints, including cough, sore throat, rhinorrhoea,
dyspnoea, nausea, vomiting, diarrhoea, headaches, chest
pain, abdominal pain, dysuria and bleeding. He had
undergone cholecystectomy 10 years prior. He was born in
the People’s Republic of China, worked in Singapore for
the previous 2 years as a construction worker and his last
travel was to China (Jiangsu province) two months prior to
presentation. He denied drug, tobacco and alcohol abuse, as
well as any high-risk sexual contact.
Apart from pyrexia (38.6 C), his physical examination
was unremarkable. He was sent home on antipyretics. Two
days later, his full blood count, ordered by a private pri-
mary care physician, showed leukopaenia (1.3 9 109/L;
normal range 4.0–11.0 9 109/L), thrombocytopaenia
(75 9 109/L; normal range 150–400 9 109/L) and normal
Fig. 2 ST-segment elevation
Fig. 3 ST-segment normalisation
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values of haemoglobin (15.4 g/dL; normal range
13.5–18.0 g/dL) and haematocrit (46.3 %; normal range
38–52 %). On the sixth day of illness, he was admitted
under the Infectious Diseases service due to loss of appe-
tite, severe vomiting, nausea, malaise, mild headaches and
dizziness. Upon physical examination, a generalised ma-
culopapular rash was noted, with petechiae over his lower
limbs; he was alert with a tympanic temperature of
37.3 C; heart rate 109 bpm; respiratory rate 20/min;
supine blood pressure 107/68 mmHg and sitting blood
pressure 107/73 mmHg. Signs of meningeal irritation were
absent. Laboratory data of relevance included thrombocy-
topaenia (27 9 109/L; normal range 170–420 9 109/L),
haematocrit value of 50 % (normal range 41–51 %), hae-
moglobin level of 16.9 g/dL (normal range 13–17 g/dL),
normal leukocyte count (4.5 9 109/L; normal range
3.6–9.3 9 109/L), increased serum creatinine level of
115 lmol/L (normal range 60–105 lmol/L) and elevation
of aminotransferases [alanine aminotransferase: 115 U/L
(normal range 17–63 U/L); aspartate aminotransferase:
64 U/L (normal range 15–41 U/L)]. His coagulation profile
was normal. Chest radiography showed neither pulmonary
consolidations nor pleural effusions. Intravenous hydration
with 0.9 % normal saline solution (1,500 mL at 62.5 mL/h)
was started. Less than 12 h following admission, the patient
was reported to be restless and collapsed and died. The
autopsy report revealed, as the final cause of death, acute
myocarditis complicating dengue infection based on the
presence of multiple areas of myocardial necrosis sur-
rounded by inflammatory cellular infiltrate. DENV-2 was
detected by reverse transcriptase polymerase chain reaction
(RT-PCR). Positive dengue serology was also found. Other
viral infections were excluded, including Chikungunya
(serum PCR), common enteroviruses (brain and heart tis-
sue cultures), common respiratory viruses (lung tissue
culture and immunofluorescence), mumps (brain tissue
culture), measles (brain tissue culture) and herpes simplex
virus (brain tissue culture and serology). Additionally,
serologic tests also excluded the following infections:
human immunodeficiency virus, viral hepatitis (A, B and
C), Epstein–Barr virus and cytomegalovirus. Blood cul-
tures yielded no bacterial growth.
Discussion
Using the current World Health Organization (WHO)
dengue classification of 2009, both cases are classified as
severe dengue due to major organ involvement (heart). Both
patients had warning signs at admission, essentially, severe
thrombocytopaenia simultaneous with increased haemato-
crit in the first case and persistent vomiting in the second.
Dengue haemorrhagic fever (DHF) criteria, as outlined by
the previous dengue classification (WHO, 1997), were not
fulfilled in either of the cases, as significant recorded hae-
moconcentration ([20 %) or evidence of plasma leakage
was lacking. However, in the first case, some doubts may
arise as the baseline haematocrit value was unknown and
with mild elevation at presentation but without documen-
tation of a 20 % or higher rise. The strict criteria for DHF in
the WHO 1997 classification may miss certain cases of
severe dengue disease [7]. This has been addressed in the
WHO 2009 guidelines with specific inclusion of severe
bleeding and severe organ involvement as separate cate-
gories of severe dengue disease, as well as in a regional
update to the 1997 guidelines, which covers unusual or
atypical manifestations under the category of Expanded
Dengue Syndrome independent of DHF status [8].
A recent dengue secondary infection cannot be excluded
in both cases due to the presence of positive IgM and IgG
serology collected in the acute phase (sixth day of illness)
[9]. The identification of DENV-2 in the second case is
consistent with DENV-2 as the most prevalent dengue
serotype circulating in Singapore, responsible for around
70 % of cases [1]. To date, three DENV serotypes have
been reported as causing acute myocarditis, specifically:
DENV-2 documented in 17 Indian children with DHF and/
or dengue shock syndrome (DSS) during the 1996 outbreak
in the Delhi region; DENV-3 in three Sri Lankan adult
patients with myocarditis detected in the early phase of
infection during an outbreak in Kandy district in 2005 and
DENV-1 in a Colombian child with DHF and fulminant
myocarditis in the 2004 outbreak in Neiva city [5, 10, 11].
Notwithstanding that cardiac involvement during dengue
infection has been occasionally reported since the 1940s
supported by immunohistochemistry and histopathological
studies, its impact on morbidity and mortality remains
unclear, probably denoting the lack of notification and/or
diagnosis [6, 12, 13].
The two cases reported here are not unique; however,
they exemplify the spectrum of myocarditis presentation,
severity and outcome. There have been reports of acute
myocarditis, as well as myopericarditis, pericarditis,
asymptomatic myocardial dysfunction and cardiac rhythm
disturbances, such as atrioventricular blocks, sinus node
dysfunction, ventricular ectopic beats, atrial fibrillation,
ST-segment and T-wave changes, tachycardia and brady-
cardia [3, 14–19]. Electrocardiogram abnormalities have
been reported during the entire course of dengue. A Viet-
namese observational study reported 35 % cardiac
involvement in early dengue, compared with 62.5 % (75/
120) during an outbreak in Sri Lanka [17, 20]. Relative
bradycardia in dengue patients has been reported in Sin-
gapore [21]. In some occurrences, as documented in the
first report, the cardiac impairment is clinically transient
and occurs during the critical phase, when patients are
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prone to be haemodynamically unstable. In other situa-
tions, such as in the second report, the evolution can be
fulminant [22]. Therefore, the clinical spectrum of myo-
carditis is far from homogeneous. It has been demonstrated
that patients with DSS are more prone to myocardial
depression with reduction of the left and/or right ventric-
ular function. One study performed in Thailand involving
99 paediatric patients revealed that approximately one-
third (9/25) of DSS patients had a ventricular ejection
fraction less than 50 % at the critical stage [23]. On the
other hand, myocarditis can be completely asymptomatic,
as shown by a study conducted in Sri Lanka, revealing
24 % (44/85) of dengue patients with echocardiographic
evidence of myocarditis, without any cardiac complaints
and with complete resolution during convalescence [3].
Nevertheless, symptomatic myocarditis had a substantial
impact, around 12.4 % (13/105) in paediatric DHF patients
during an outbreak in Colombia (Neiva city, 2004) [24].
The cardiac involvement was confirmed by histology in
the second case and by the ECG and echocardiogram in the
first case. Serum biomarkers of myocardial injury, namely,
increased troponin I, were helpful to confirm diagnosis.
However, most myocarditis patients do not have elevated
levels of cardiac biomarkers [25].
Recent expert opinions highlighted the detrimental
effect of obesity in fluid management and a more severe
outcome in dengue due to the complications of capillary
leakage. The first patient was moderately obese; however,
this anecdotal case cannot determine the effect of obesity
on dengue severity. Regarding this issue, published studies
are scarce and the literature focused on the paediatric
population, but obesity was found to be a major risk factor
for acute kidney injury in Thai children with DHF, as well
as a risk for unusual presentations or shock [26, 27].
Conclusions
Myocardial injury secondary to dengue can lead to fatal
outcome. Ventricular function may be temporarily com-
promised during dengue infection. Echocardiography is an
important tool to assess and rule out other causes of heart
failure.
Dengue myocarditis is generally reversible, with a
favourable outcome if diagnosed and treated early. Fur-
thermore, in order to provide adequate and efficient sup-
portive therapy avoiding major organ impairment, it is
crucial to diagnose dengue as early as possible, using either
laboratory methods such as reverse transcriptase polymer-
ase chain reaction (RT-PCR) and dengue-specific antigen
and antibody enzyme-linked immunosorbent assays (ELI-
SAs) where available, or lateral-flow-based immunochro-
matographic rapid diagnostics tests.
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